Litigation Details for Intercept Pharmaceuticals, Inc. v. Apotex Inc. (D. Del. 2020)
✉ Email this page to a colleague
Intercept Pharmaceuticals, Inc. v. Apotex Inc. (D. Del. 2020)
| Docket | ⤷ Sign Up | Date Filed | 2020-08-21 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
| Jury Demand | None | Referred To | |
| Patents | 10,047,117; 10,052,337; 10,174,073 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Intercept Pharmaceuticals, Inc. v. Apotex Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Intercept Pharmaceuticals, Inc. v. Apotex Inc. (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2022-03-23 | 142 | Order - -Memorandum and Order | terms of U.S. Patent Nos. 9,238,673 (“the ’673 Patent”), 10,047,117 (“the ’117 Patent”), 10,174,073 …of the ’673 Patent, the ’117 Patent, the ’337 Patent, the ’349 Patent, and the ’549 Patent are construed…10,174,073 (“the ’073 Patent”), 10,052,337 (“the ’337 Patent”), 10,751,349 (“the ’349 Patent”), and 10,758,549… matter” (’337 Patent, claims 1–8; ’349 Patent, claims 1, 19; ’549 Patent, …meaning (’337 patent, claim 11; ’349 patent, claim 4; ’549 patent, claims 12, 23 | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
